| P2093 | author name string | D Wolff | |
| | E Holler | |
| | M Landthaler | |
| | S Karrer | |
| | M Beckers | |
| | R Travnik | |
| P2860 | cites work | Graft-versus-host disease | Q83468020 |
| | Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients | Q84877269 |
| | Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission | Q24539030 |
| | Allogeneic hematopoietic stem cell transplantation: complications and results | Q30309645 |
| | The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation | Q33898254 |
| | How I treat chronic graft-versus-host disease | Q34164471 |
| | Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation | Q34186689 |
| | Unrelated donor hematopoietic transplantation | Q34326698 |
| | National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 |
| | The Pathophysiology of Acute Graft-versus-Host Disease | Q35578563 |
| | Graft-versus-host disease of the skin: life and death on the epidermal edge. | Q35775843 |
| | Update on graft versus host disease | Q35831700 |
| | Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. | Q35889876 |
| | Cutaneous graft-versus-host disease: a guide for the dermatologist | Q37071554 |
| | Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD | Q37791005 |
| | Bone-marrow transplantation (second of two parts). | Q38091044 |
| | 1994 Consensus Conference on Acute GVHD Grading | Q39513397 |
| | Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease. | Q39929451 |
| | Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation | Q40516766 |
| | Parafollicular hair bulge in human GVHD: a stem cell-rich primary target. | Q40894206 |
| | Inflammatory reactions induced by pretransplant conditioning--an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation? | Q40898694 |
| | Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease | Q41640832 |
| | Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT. | Q53132188 |
| | Graft-versus-host disease | Q68195420 |
| | Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors | Q70055061 |
| | Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation | Q70582290 |
| | Bone marrow transplantation | Q72258978 |
| | Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants | Q73205710 |
| | Late appearance of acute graft-vs-host disease after suspending or tapering immunosuppressive drugs | Q73437003 |
| | [Cutaneous graft-versus-host disease] | Q73591186 |
| | [Transplantation of hematopoietic stem cells. I: Definitions, principle indications, complications] | Q73811908 |
| | Graft-versus-host reactions in dermatology | Q74371912 |
| | Cutaneous graft-versus-host disease | Q74599444 |
| | Cytokines in GvH and GvL | Q77899348 |
| | The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation | Q79768217 |
| | Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal | Q80585680 |
| | [Graft-versus-host disease: a dermatologic view of an interdisciplinary problem] | Q81474846 |
| | Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination | Q82312167 |
| | Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis | Q82615572 |
| | The NIH consensus criteria for chronic graft-versus-host disease: far more than just another classification | Q83182897 |
| P433 | issue | 2 | |
| P304 | page(s) | 139-54; quiz 155 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Die Dermatologie | Q15756740 |
| P1476 | title | [Graft-versus-Host Disease (GvHD) - an update : Part 1: Pathophysiology, clinical features and classification of GvHD] | |
| P478 | volume | 62 | |